Novo Nordisk cuts forecasts amid U.S. drug rivalry, but reports strong Q1 results and responds with expanded access and price cuts.
Expeditors' strong Q1 2025 results beat expectations, but shares dropped amid ongoing trade policy uncertainty and signs of declining ocean volumes.
Former President Biden strongly criticizes Trump's 'modern-day appeasement' approach to Russia and Ukraine, warning that conceding territory would embolden Putin.
Novo Nordisk cuts forecasts amid U.S. drug rivalry, but reports strong Q1 results and responds with expanded access and price cuts.
Expeditors' strong Q1 2025 results beat expectations, but shares dropped amid ongoing trade policy uncertainty and signs of declining ocean volumes.
Former President Biden strongly criticizes Trump's 'modern-day appeasement' approach to Russia and Ukraine, warning that conceding territory would embolden Putin.